Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas

(2009) Marc-Oliver Riener et al.   HEPATOLOGY

Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

(2009) Sean F. Altekruse et al.   JOURNAL OF CLINICAL ONCOLOGY

Hepatocellular carcinoma in the Asia pacific region

(2009) Man-Fung Yuen et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population

(2009) Jin-song Hu et al.   MEDICAL ONCOLOGY

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics

(2008) G Kristiansen et al.   BRITISH JOURNAL OF CANCER

Diagnosis and Treatment of Hepatocellular Carcinoma

(2008) Hashem B. El-Serag et al.   GASTROENTEROLOGY

N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing

(2008) Valerie Vanhooren et al.   MECHANISMS OF AGEING AND DEVELOPMENT

Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases

(2008) Y. Gu et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

(2007) Masatoshi Makuuchi et al.   HEPATOLOGY RESEARCH